Rapid in vitro biocompatibility assay of endovascular stents by flow cytometry using platelet activation and platelet-leukocyte aggregation

Communications in Clinical Cytometry

Volumn 38, Issue 1, 1999, Pages 30-39

  Tárnok, Attila ^a,b   Mahnke, Almut ^a   Müller, Matthias ^a   Zotz, Rainer J ^a  

^a UNIVERSITY OF LEIPZIG   (Germany)

^b UNIVERSITY HOSPITAL LEIPZIG   (Germany)

Author keywords

Flow cytometry; In vitro assay; Intravascular coronary stents; Platelet activation

Indexed keywords

CD14 ANTIGEN; CD45 ANTIGEN; FIBRINOGEN RECEPTOR; GOLD; HEPARIN; STAINLESS STEEL; THROMBIN RECEPTOR ACTIVATING PEPTIDE; THROMBIN RECEPTOR ACTIVATING PEPTIDE 6; UNCLASSIFIED DRUG;

ANTIGEN EXPRESSION; ARTICLE; BIOCOMPATIBILITY; CONTROLLED STUDY; DEVICE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; LEUKOCYTE ACTIVATION; LEUKOCYTE AGGREGATION; PRIORITY JOURNAL; STENT; THROMBOCYTE ACTIVATION;

ADULT; ANTIGENS, CD; BLOOD VESSEL PROSTHESIS; CELL AGGREGATION; COATED MATERIALS, BIOCOMPATIBLE; FIBRINOGEN; FLOW CYTOMETRY; GOLD; HEPARIN; HUMANS; LEUKOCYTES; MALE; MONOCYTES; NEUTROPHILS; PLATELET ACTIVATION; STEEL; STENTS; TANTALUM;

EID: 0345004143     PISSN: 01964763     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0320(19990215)38:1<30::AID-CYTO5>3.0.CO;2-5     Document Type: Article

References (23)

1. Bauters C, Isner JM. The biology of restenosis. Prog Cardiovasc Dis 1997;40:107-116.
2. Fontaine AB, Koelling K, Clay J, Spigos DG, Passos SD, Christoforidis G, Hinkle G, Hill T, Cearlock J, Pozderac R. Decreased platelet adherence of polymer-coated tantalum stents. J Vasc Intervent Radiol 1994;5:567-572.
3. Hehrlein C, Zimmermann M, Metz J, Ensinger W, Kübler W. Influence of surface texture and charge on the biocompatibility of endovascular stents. Coronary Artery Dis 1995;6:581-586.
4. Rogers C, Edelmann ER. Endovascular stent design dictates experimental restenosis and thrombosis. Circulation 1995;91:2995-3001.
5. Tepe G, Duda SH, Hanke H, Schulze S, Hagmeier S, Bruck B, Schott U, Betz E, Schmahl FW, Claussen. CD Covered stents for prevention of restenosis. Experimental and clinical results with different stent design. Invest Radiol 1996;31:223-229.
6. Gawaz M, Neumann FJ, Ott I, May A, Rudiger S, Schomig A. Role of activation-dependent membrane glycoproteins in development of subacute occlusive coronary stent thrombosis. Coronary Artery Dis 1997;8:121-128.
7. Serruys PW, Emanuelsson H, van der Giessen W, Lunn AC, Kiemeney F, Macay C, Rutsch W, Heyndrickx G, Suryapranata H, Legrand V, Goy JJ, Materne P, Bonnier H, Morice MC, Fajadet J, Belardi J, Colombo A, Garcia E, Ruygrok P, de Jaegere P, Morel MA. Heparin-coated Palmaz-Schatz stents in human coronary arteries. Early outcome of the Benestent-II pilot study Circulation 1996;93:412-422.
8. Hardhammer PA, van Beusekom HM, Emanuelson HU, Hofma SH, Albertsson PA. Verdouw PD, Boersmann E, Serruys PW, van der Giessen WJ. Reduction in thrombotic events with heparin-coated Palmaz-Schatz stents in normal porcine coronary arteries. Circulation 1996;93:423-430.
9. Gutensohn K, Beythien C, Bau J, Meinertz T, Kuehnl P. Flow cytometric analysis of coronary stent-induced alterations of platelet antigens in an in vitro model. Thromb Res 1997;86:49-56.
10. Michelson AD. Flow cytometry: a clinical test of platelet function. Blood 1996;87:4925-4936.
11. Rinder CS, Gaal D. Student LA, Smith BR. Platelet-leukocyte activation and modulation of adhesion receptors in pediatric patients with congenital heart disease undergoing cardiopulmonary bypass. J Thorac Cardiovasc Surg 1994;107:280-287.
12. Rinder HM, Bonan JL, Rinder CS, Ault KA, Smith BR. Activated and unactivated platelet adhesion to monocytes and neutrophils. Blood 1991;78:1760-1769.
13. Schmitz G, Rothe G, Ruf A, Barlage S, Tschöpe D, Clemetson KJ, Goodall AH, Michelson AD, Nurden AT, Shankey TV. Consensus protocol for the flow cytometric characterisation of platelet function. Thromb Haemost 1998;79:885-896.
14. Wittig K, Rothe G. Schmitz G. Inhibition of fibrinogen binding and surface recruitment of GPIIb/IIIa as dose-dependent effects of the RGD-mimetic MK852. Thromb Haemost 1998;79:625-630.
15. Rinder HM, Murphy M, Mitchell JG, Stocks J, Ault KA, Hillmann RS. Progressive platelet activation with storage: evidence for shortened survival of activated platelets after transfusion. Transfusion 1991;31: 409-414.
16. Mahnke A, Zotz R. Kunze T, Tarnok A. Measurement of platelet arterial interactions using modified platelet function protocol and dual laser flow cytometry. Abstract book of the 10th Heidelberg Cytometry Symposium, 1997, p 53.
17. Ault KA, Rinder HM, Mitchell JG, Rinder CS, Lambrew CT, Hillmann RS. Correlated measurement of platelet release and aggregation in whole blood. Cytometry 1989;10:448-455.
18. Rinder HM, Snyder EL, Bonan JL, Napychank PA, Malkus H, Smith BR. Activation in stored platelet concentrates: correlation between membrane expression of P-selectin, glycoprotein IIb/IIIa, and β-thromboglobulin release. Transfusion 1993;33:25-29.
19. Rinder HM, Snyder EL. Activation of platelet concentrate during preparation and storage. Blood Cells 1992;18:445-456.
20. Diacovo TG, de Fougerolles AR, Bainton DF, Springer TA. A functional integrin ligand on the surface of platelets: intracellular adhesion molecule-2. J Clin Invest 1994:94:1243-1251.
21. De Scheerder I, Wang K, Wilczek K, Meulemann D, Van Amsterdam R, Vogel G, Piessens J, Van de Werf F. Experimental study of thrombogenicity and foreign body reaction induced by heparin-coated coronary stents. Circulation 1997;95:1459-1553.
22. Amirkhosravi A, Alexander M, May K, Francis DA, Warnes G, Biggerstaff J, Francis JL. The importance of platelets in the expression of monocyte tissue factor antigen measured by a new whole blood flow cytometric assay. Thromb Haemost 1996;75:87-95.
23. Neumann FJ, Marx N, Gawaz M, Brand K, Ott I, Rokitta C, Sticherling C, Meinl C, May A, Schoemig A. Induction of cytokine expression in leukocytes by binding of thrombin-stimulated platelets. Circulation 1997;95:2387-2394.